20/12/2014 10:04:18 Free Membership Login

   

Antigenics

Visual Financials
Company Name: Agenus, Inc.
Ticker Symbol: AGEN
WWW Address: http://www.antigenics.com
CEO: Garo Armen
No. of Employees: 53
Common Issue Type: CS
Business Description:Agenus, Inc. is a biotechnology company, which is developing and commercializing technologies to treat cancers and infectious diseases, based on immunological approaches.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 4.0 Up 0.07 4.0 4.02 4.06 4.26 3.92 2866601
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 250.7 62.7 0.00 -1.12 0.00 0.0 0.0 5.27 - 2.27
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close3.99$
PE Ratio - LTM0.0
Market Capitalisation250.7mil
Latest Shares Outstanding62.7mil
Earnings pS (EPS)-1.12$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float50.0mil
Float as % of Shares Outstanding0.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue4.80%
Research & Devlopment (R&D) as % of Revenue4.30%
Gross Profit Margin82.4%
EBITDA Margin-888.6%
Pre-Tax Profit Margin0.0%
Assets Turnover9.5%
Return on Assets (ROA)-104.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio2.7
Leverage Ratio (Assets/Equity)
Interest Cover-11.4
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.29$
Cash pS0.00$
Book-Value pS0.78$
Tangible Book-Value pS-0.11$
Cash Flow pS-0.63$
Free Cash Flow pS-0.65$
KEY FIGURES (LTM): Price info
Price/Book Ratio4.13
Price/Tangible Book Ratio0.00
Price/Cash Flow-5.1
Price/Free Cash Flow-5.0
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---4.264.304122
4 Weeks4.263.923.924.264.30435
13 Weeks3.993.9928652802.875.27335
26 Weeks28652804.264.262.935.27334
52 Weeks2.902.902.934.262.27334
YTD2.272.27-4.262.271043
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
2.562.562.912.914.260.190.19
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue152073041247105512471055
Income152073041520730429797012
Dividend297970128465290684652906
Capital Spending180255096NA180255096
R&D13932972NA13932972
Normalized Inc.29797012NA29797012
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %11-20-20
Earnings %383828
EPS %718080
EPS $286666
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio34835481
Quick Ratio (Acid Test)6660903
Liquidity Ratio (Cash)0.00
Receivables Turnover1660679
Average Collection Period
Working Capital/Equity
Working Capital pS347
Cash-Flow pS347
Free Cash-Flow pS-4481050
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)834740
Debt Ratio39316184
Total Debt/Equity (Gearing Ratio)St
LT Debt/Equity20478812
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities39316184
Interest Cover-27637443
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM85,149,793.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow-21.32
Dividend Yield7617595
Price/Tangible Book Ratio - LTM32
Price/Book Ratio - LTM714837
Price/Cash Flow Ratio2.7
Price/Free Cash Flow Ratio - LTM32
Price/Sales Ratio32.00
P/E Ratio (1 month ago) - LTM85149793
P/E Ratio (26 weeks ago) - LTM127132739
P/E Ratio (52 weeks ago) - LTM127132739
5-Y High P/E Ratio180853909
5-Y Low P/E Ratio177861742
5-Y Average P/E Ratio1188419
Current P/E Ratio as % of 5-Y Average P/E1188419
P/E as % of Industry Group760,365.0
P/E as % of Sector Segment760,365.0
Current 12 Month Normalized P/E Ratio - LTM1,133,732.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM2.7
Book Value pS - LTM714837
Capital Invested pS0.00
Cash pS - LTM2411
Cash Flow pS - LTM2.33
Free Cash Flow pS - LTM2.33
Earnings pS (EPS)-95
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-27637443
Net Profit Margin - 5YEAR AVRG.2014-10-27
Equity Productivity0.00
Return on Equity (ROE)-4481050
Return on Equity (ROE) - 5YEAR AVRG.201843977
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-98
Assets Productivity834,740.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.201843977
Gross Profit Margin760365
Gross Profit Margin - 5YEAR AVRG.-98
EBITDA Margin - LTM458415
EBIT Margin - LTM760365
Pre-Tax Profit Margin2784845
Pre-Tax Profit Margin - 5YEAR AVRG.62684465
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle10,296,194
Revenue per Employee
Net Income per Employee2,572,203
Average Collection Period
Receivables Turnover1660679
Day's Inventory Turnover Ratio10295873
Inventory Turnover1660679
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover834740
Revenue per $ Cash4215221
Revenue per $ Plant4215221
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.62684465
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq agen141220 10:04